Production of Fibrinolytic Enzyme by Soil Actinobacteria
Production of Fibrinolytic Enzyme by Soil Actinobacteria
DOI:
https://doi.org/10.53560/PPASB(60-1)733Keywords:
Actinobacteria, Semi-Arid, Fibrinolytic Enzyme, Yield optimization, ThrombolyticAbstract
Thrombotic diseases are increasingly becoming among the prominent causes of death across the globe. Researchers are now turning attention towards fibrinolytic enzymes as potential alternative treatment for thrombolytic diseases. This present study focused on the production of extracellular fibrinolytic enzyme from soil Actinobacteria and evaluation of its hydrolytic activity on blood clot. The Actinobacteria was isolated from compost soil of semi-arid climate in Nigeria. Bacterial isolation was achieved using starch casein agar. Potent fibrinolytic enzyme producing Actinobacteria were identified and subjected to enzyme production using submerged fermentation method. The interactive effects of incubation time, temperature, pH and media components on enzyme production were analysed. Extracellular fibrinolytic enzyme produced by the selected Actinobacteria was partially purified by ammonium sulphate precipitation and subsequently assayed for blood clot lysis activity. Results of these studies indicated that fibrinolytic enzyme was produced optimally at pH 8 and temperature of 40 oC after 72 hour of fermentation. Partially purified fibrinolytic enzyme was able to degrade blood clot comparable to the positive control. These results shows that soil Actinobacteria of unexplored semi-arid climate of Nigeria present a prospect in search of novel microorganisms with potentials in the production of fibrinolytic enzyme that can serve as an alternative blood clot buster in treating thrombolytic diseases.
References
E. Boersma, N. Mercado, D. Poldermans, M. Gardien, J. Vos, M.L. Simoons. Acute myocardial infarction. Lancet 361: 847–858 (2003).
S. Blix. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy: A new method for determination of preformed clot lysis. Acta Medica Scandinavica 172: 1–24 (1962).
M.E.A. Alkhider, E.E. Elkhidir, and H.M. Ibrahim. Optimization of physical conditions of Actinokinase synthesis from local isolate using response surface methodology (RSM). Journal of Applied Sciences 20: 35-40 (2020).
J.R. Simkhada, P. Maner, S.S. Cho, and J.C. Ydoo. A novel fibrinolytic protease from Streptomyces sp. CS684. Process Biochemistry 45(1): 88–93 (2010).
X. Ju, X. Cao, Y. Sun, Z. Wang, C. Cao, J. Liu, and J. Jiang. Purification and characterization of a fibrinolytic enzyme from Streptomyces sp. XZNUM 00004. World Journal of Microbiology and Biotechnology 28(7): 2479–2486 (2012).
S. Pan, G. Chen, J. Zeng, X. Cao, X. Zheng, W. Zeng, and Z. Liang.. Fibrinolytic enzyme production from low-cost substrates by marine
Bacillus subtilis: Process optimization and kinetic modelling. Biochemical Engineering Journal 141: 268–277 (2019).
V.G. Nielsen, J.K. Kirklin, W.L. Holman, and B.L. Steenwyk. Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: Role of contact protein and tissue factor initiation. ASAIO Journal 55: 33–40 (2009).
S.N. Hazarika, and D. Thakur. Beneficial Microbes in Agro-Ecology. Bacteria and Fungi. Elsevier chapter-21 Actinobacteria p. 443-476 (2020).
C.V. Dilip, S.S. Mulaje, and R.Y. Mohalkar. A review on actinomycetes and their biotechnological application. International Journal of
Biopharmaceuticals Science Research 4: 1730–1742 (2013).
V. Mohanasrinivasan, S. Yogesh, A. Govindaraj, J.S. Naine, and S.C Devi. In vitro thrombolytic potential of actinoprotease from marine
Streptomyces violaceus VITYGM. Cardiovascular and Hematological Agents in Medicinal Chemistry 14: 120–124 (2016).
B. Naveena, K.P. Gopinath, P. Sakthiselvan, and N. Partha. Enhanced production of thrombinase by Streptomyces venezuelae: Kinetic studies on growth and enzyme production of mutant strain. Bioresource Technology. 1: 417–424 (2012).
P. Verma, S. Chatterjee, M.S. Keziah, and S.C. Devi, S.C. Fibrinolytic Protease from Marine Streptomyces rubiginosus VITPSS1. Cardiovascular & Hematological Agents in Medicinal Chemistry 16: 44-55 (2018).
D. Dhamodharan, N.S. Jemimah, K.S. Merlyn, and D.C. Subathra. Novel fibrinolytic protease producing Streptomyces radiopugnans VITSD8 from marine sponges. Marine Drugs 17:164 (2019).
N. Prabhu, T. Gajendran, S. Karthikadevi, A. Archana, and R. Arthe. Utilization of sugarcane bagasse for enhancement production of fibrinolytic enzyme using statistical approach. Cleaner Engineering and Technology 5:100269 (2021).
S.A. Gopinath, and K. Lingappa. Isolation and screening of fibrinolytic enzymes producing bacterium strain from soil waste. International Journal of Current Microbiology and Applied Sciences 5(7): 969–976 (2016).
T. Astrup, and S. Müllertz. The fibrin plate method for estimating fibrinolytic activity. Archive of Biochemistry and Biophysics 40(2): 346–351 (1952).
S.B. Kim, D.W. Lee, C.I. Cheigh, E.A. Choe, S.J. Lee, Y.H. Hong, H.J. Choi, and Y.R. Pyun. Purification and characterization of a fibrinolytic subtilisin-like protease of Bacillus subtilis TP-6 from an Indonesian fermented soybean, Tempeh. Journal of Industrial Microbiology and Biotechnology 33(6): 436–444 (2006).
P.L. Bhargavi, and R.S. Prakasham, A fibrinolytic, alkaline and thermostable metalloprotease from the newly isolated Serratia sp RSPB11. International Journal of Biological Macromolecules 61: 479–486 (2013).
P. Hariharan, C.C. Naik, P. Vajpaye, and K. Srinivasa. Production, purification and characterization of thrombolytic enzyme from Cladosporium spp. through solid state fermentation. International Journal of Engineering 3: 585-589 (2014).
P. Vijayaraghavan, A. Arun, S.G.P. Vincent, M.V. Arasu, and N.A. Al-Dhabi. Cow dung is a novel feedstock for fibrinolytic enzyme production from newly isolated Bacillus sp. IND7 and its application in in vitro clot lysis. Frontiers in Microbiology 7:361 (2016).
K. Taneja, B. Kumar, S. Kumar, N. Dilbaghi. Process optimization for production and purification of novel fibrinolytic enzyme from Stenotrophomonas sp. KG-16-3. Biocatalysis and Biotransformation 37 (2): 124–138 (2019).
B.K. Bajaj, S. Singh, M. Khullar, K. Singh, and S. Bhardwaj. Optimization of fibrinolytic protease production from Bacillus subtilis I-2 using agroresidues. Brazilian Archive of Biological Technology 57 (5): 653–662 (2014).
S. Khankari, A. Badoei-dalfard, and Z. Karami. Cross-linked Enzyme Aggregates of Fibrinolytic Protease BC1 Immobilized on Magnetic Chitosan Nanoparticles (CLEAs-Fib-mChi): Synthesis, Purification, and Characterization. Applied Biochemistry and Biotechnology 193: 2004-2027 (2021).
A. Krishnamurth, and P.D. Belur. A novel fibrinolytic serine metalloprotease from the marine Serratia marcescens subsp. sakuensis: Purification and characterization. International Journal of Biological Macromolecules 112: 110–118 (2018).
S. Prasad, R.S. Kashyap, J.Y. Deopujari, H.J. Purohit, G.M. Taori, and H.F. Daginawal. Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thrombosis Journal 4: 1–4 (2006).
Downloads
Published
How to Cite
Issue
Section
License
Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.
